Novartis

Novartis plots 2nd U.S. factory to meet demand for Lutathera and future cancer radiotherapies
Fierce Pharma
Wed, 07/1/20 - 11:17 am
Novartis
Lutathera
radiotherapy
drug manufacturing
Takeda takes a $200M hit after Novartis is forced to yank its marketing application for Xiidra
Endpoints
Mon, 06/29/20 - 10:26 am
Takeda
Novartis
Xiidra
Europe
EMA
dry eye disease
'No presents anymore': Inside Novartis' scheme to boost Lucentis sales in Greece
Fierce Pharma
Fri, 06/26/20 - 01:08 pm
Novartis
Greece
DOJ
Lucentis
kickbacks
physicians
Novartis strikes out with dry eye med Xiidra in Europe
Seeking Alpha
Fri, 06/26/20 - 09:52 am
Novartis
dry eye disease
Europe
Xiidra
CHMP
Novartis inks settlements worth $347M with DOJ, SEC over foreign doctor payments, records keeping
Fierce Pharma
Thu, 06/25/20 - 08:39 pm
Novartis
DOJ
kickbacks
physicians
FCPA
SEC
With cell and gene therapy boom coming, experts at Novartis, Kite trumpet need for capacity: panel
Fierce Pharma
Wed, 06/24/20 - 11:21 pm
cell therapy
gene therapy
Novartis
Kite Pharma
Biomarin
Astellas
Novartis Shuts Down Hydroxychloroquine COVID-19 Clinical Trial
Motley Fool
Mon, 06/22/20 - 08:40 pm
Novartis
clinical trials
hydroxychloroquine
COVID-19
pandemic
Novartis gets FDA approval for Cosentyx to treat active non-radiographic axial spondyloarthritis
Pharmaceutical Business Review
Thu, 06/18/20 - 10:32 am
Novartis
Cosentyx
non-radiographic axial spondyloarthritis
Novartis takes aim at Eli Lilly with Cosentyx FDA nod in spondyloarthritis
Fierce Pharma
Wed, 06/17/20 - 09:57 am
Novartis
Eli Lilly
Cosentyx
Taltz
spondyloarthritis
UCB’s growth driver squares up against the competition
EP Vantage
Thu, 06/11/20 - 12:20 pm
UCB Pharma
bimekizumab
psoriasis
clinical trials
Novartis
Cosentyx
FDA Delays Ruling on Novartis’ Relapsing Multiple Sclerosis Drug
BioSpace
Wed, 06/3/20 - 11:08 am
Novartis
Arzerra
FDA
ofatumumab
relapsing multiple sclerosis
Eli Lilly's Taltz beats Novartis to the punch with FDA approval in spondyloarthritis
Fierce Pharma
Mon, 06/1/20 - 11:32 pm
Eli Lilly
Taltz
Novartis
Cosentyx
axial spondyloarthritis
Big gene therapy names line up behind experimental Covid-19 vaccine
Stat
Thu, 05/28/20 - 10:44 am
COVID-19
gene therapy
Novartis
AveXis
Novartis builds case for MS drug ofatumumab as FDA decision looms
Pharmaforum
Wed, 05/27/20 - 10:22 am
Novartis
ofatumumab
clinical trials
MS
multiple sclerosis
New Zolgensma 'inflection point' is here as Novartis snags EU nod for SMA gene therapy
Fierce Pharma
Wed, 05/20/20 - 10:50 am
Novartis
Zolgensma
SMA
spinal muscular atrophy
gene therapy
Europe
Novartis taps Iya Khalil, physicist co-founder of GNS Healthcare, to lead AI Innovation Center
Endpoints
Tue, 05/19/20 - 11:16 pm
Novartis
Iya Khalil
GNS Healthcare
artificial intelligence
innovation
With bucks from Pfizer added to their new round, Amplyx steers a tricky course through PhII and a global pandemic
Endpoints
Tue, 05/19/20 - 10:30 am
Amplyx
Pfizer
Novartis
Teva bails on price-fixing settlement in gamble on its role fighting COVID-19: report
Fierce Pharma
Mon, 05/18/20 - 10:56 pm
Teva Pharmaceutical
price fixing
generics
COVID-19
Sandoz
JNJ
Novartis
Taro Pharmaceuticals
Novartis CEO: COVID-19 vaccine might take until end of 2021 to reach patients
Fierce Pharma
Fri, 05/15/20 - 10:58 am
Novartis
Pharma CEOs
vaccines
pandemic
COVID-19
Vas Narasimhan
Novartis-backed Gamida hits goal in phase 3 cancer trial
Fierce Biotech
Tue, 05/12/20 - 12:04 pm
Gamida Cell
Novartis
omidubicel
blood cancer
clinical trials

Pages